References
- Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin. A new antineoplastic agent. Cancer 1973; 31: 905
- Bonadonna G., DeLena M., Monfardini S., Bartoli C., Bajett E., Beretta G., Fossati-Bellani F. Clinical trials with bleomycin in lymphomas and in solid tumors. Europ. J. Cancer 1972; 8: 205
- Catane R., Scwade J. G., Turrisi A. T., Webber B. L., Muggia F. M. Pulmonary toxicity after radiation and bleomycin. A review. J. Radiat. Oncol. Biol. Phys. 1979; 5: 1513
- Cole P. Drug induced lung disease. Drug 1977; 13: 422
- Comis R. L. Bleomycin pulmonary toxicity. Bleomycin. Current status, S. K. Carter, H. Umezawa, S. T. Crooke. Academic Press, New York 1978; 279
- Comis R. L., Kuppinger M. S., Ginsberg S. J., Crooke S. T., Gilbert R., Auchincloss J. H., Prestayko A. W. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res. 1979; 39: 5076
- Cooper K. R., Hong W. K. Prospective study of the pulmonary toxicity of continuously infused bleomycin. Cancer Treatm. Rep. 1981; 65: 419
- Crooke S. T., Bradner W. T. Bleomycin, a review. J. Med. (Basel) 1976; 7: 333
- DeLena M., Guzzon A., Monfardini S., Bonadonna G. Clinical, radiologic and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066). Cancer Chemother. Rep. 1972; 56: 343
- Gebbels J.-O., Burkhardt A., Höltje W. J. Morphologische Lungenveränderungen nach Bleomycin Therapie. Ver. Dtsch. Ges. Path. 1975; 59: 561
- Haas C. D., Coltman C. A., Jr, Gottlieb J. A., Haut A., Luce J. K., Talley R. W., Samal B., Wilson H. E., Hoogstraten B. Phase II evaluation of bleomycin. A Southwest Oncology Group Study. Cancer 1976; 38: 8
- Hoogstraten B., Haas C. D., Haut A. CCNU and bleomycin in the treatment of cancer. A Southwest Oncology Group Study. Med. Pediatr. Oncol. 1975; 1: 106
- Lewis B. M., Izbicki R. Routine pulmonary function tests during bleomycin therapy. Tests may be ineffective and potentially misleading. J. Amer. med Ass. 1980; 243: 347
- Lown J. W., Sim S. The mechanism of the bleomycin-induced cleavage of DNA. Biochem. Biophys. Res. Commun. 1977; 77: 1150
- McCullough B., Collins J. F., Johanson W. G., Jr, Groven F. L. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. J. clin. Invest. 1978; 61: 79
- Richman S. D., Levenson S. M., Blum P. A., Flinn G. S., Johnston G. S., DeVita V. T. 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity. Cancer 1975; 36: 1966
- Rygårdh J., Hansen H. S. The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation. Progr. Biochem. Pharmacol. 1976; 11: 11
- Sicic B. J., Young D. M., Mimnaugh E. G., Gram T. E. Quantification of bleomycin pulmonary toxicity in mice by changes in lung hydroxyproline content and morphometric histopathology. Cancer Res. 1978; 38: 787
- Umezawa H. Studies on bleomycin. Chemistry and the biological action. Biomedicine 1973; 18: 459